Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks…
Latest Testing & QA news from Tech News
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks…
The San Francisco startup aims to help battery and chip manufacturers identify defects on production lines, reducing downtime and costly mistakes.
The clock is almost out. You have less than 24 hours left to apply to host a Side Event during TechCrunch Founder Summit 2026. Applications close to…
VC Chris Degnan and former board advisor to Factory AI has taken a job as chief revenue officer for Cognition.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-…
3 days to save up to $200 on your TechCrunch Disrupt 2026 pass, plus 50% off a second. Make impactful connections with 10,000+ tech leaders. Last da…
Blacksmith says revenue has grown more than tenfold over the past year.
Cybersecurity startup Horizon3 raised $250 million at a $2 billion valuation as companies want continuous, AI-powered security validation instead of…
Salome Mikadze-Struk is no stranger to adversity. The daughter of refugees, she built a software-development business as an undergraduate at the hei…
Startup Battlefield 200 applications are open, but only for three more weeks. Apply by May 27 for your shot at VC access, global visibility, TechCru…